This study was conducted to evaluate the efficacy of the MEtabolic Syndrome REduction in NAvarra (RESMENA) diet versus a control diet based on American Heart Association (AHA) recommendations for the treatment of PCOS in adolescents with obesity and PCOS. A total of 40 adolescents diagnosed with PCOS between the ages of 13-18 years were randomized to either a Resmena or control diet for 6 months. Dietary status, anthropometry, body composition, biochemical parameters, and reproductive endocrine hormones were compared between the 2 groups before and after the intervention.
The purpose of this study was to investigate the effect of a high meal frequency, low carbohydrate, high protein, high n-3 PUFA, healthy fatty acid and antioxidant content, low glycemic load Resmena diet or a control diet based on AHA recommendations on anthropometric measurements, body composition, insulin resistance, lipid metabolism levels, inflammatory markers and reproductive endocrine levels in adolescents with obesity and PCOS..Randomized controlled study design was used in the study. Patients in the study were allocated to the control and study intervention groups. Participants were invited to face-to-face interviews at the beginning of the study and monthly for 6 months. Anthropometric measurements, body composition analysis, and a physical activity questionnaire were performed at the beginning and end of the study, and three-day food consumption records and blood samples for the measurement of biochemical parameters were collected. In addition, the physical activity and food consumption records of the participants were repeated in monthly controls and their anthropometric measurements and body composition were analyzed and compared.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
40
The Resmena diet: It was characterized by a higher meal frequency, consisting of seven meals/d (including breakfast, lunch, dinner, and two snacks in the morning and two snacks in the afternoon), and by a different macronutrient distribution; 40% total energy value from CHO, 30% from proteins and 30% from lipids. This pattern tried to reinforce high n-3 polyunsaturated FA (n-3 PUFA) and high natural antioxidant food consumption and promoted low GL CHO intake as well as a high adherence to the Mediterranean diet. It also maintained a healthy FA profile and a cholesterol content of less than 300 mg/day. * Daily meal plans were created according to the energy intake of the participants and sent to the participants via social media every week. Participants were asked to keep 3-day diet records to evaluate their compliance with the diet and were invited to the research center once a month to be checked.
Control diet: It was based on the American Heart Association (AHA) guidelines, including 3-5 meals per day, a macronutrient distribution of 55% total energy value from carbohydrates, 15% proteins, and 30% lipids, a healthy fatty acids (FA) profile and a cholesterol consumption lower than 300 mg/day. \- Daily meal plans were created according to the energy intake of the participants and sent to the participants via social media every week. Participants were asked to keep 3-day diet records to evaluate their compliance with the diet and were invited to the research center once a month to be checked
Esra Döğer
Ankara, Turkey (Türkiye)
Luteinizing hormone (LH) (IU/L)
Participants' serum LH levels was determined.
Time frame: change between the first day and the sixth month of the study
Follicle-stimulating hormone (FSH) (IU/L)
Participants' serum FSH levels was determined.
Time frame: change between the first day and the sixth month of the study
Total and free (ng/mL)
Participants' serum FSH levels was determined.
Time frame: change between the first day and the sixth month of the study
Prolactin (ng/mL)
Participants' serum prolactin levels was determined.
Time frame: change between the first day and the sixth month of the study
Dehydroepiandrosterone sulfate (DHEA-S) (µg/dL)
Participants' serum DHEA-S levels was determined.
Time frame: change between the first day and the sixth month of the study
Androstenedione (ng/mL)
Participants' serum androstenedione was determined.
Time frame: change between the first day and the sixth month of the study
17-hydroxyprogesterone (17-OH progesterone) (ng/mL)
Participants' serum 17-OH progesterone was determined.
Time frame: change between the first day and the sixth month of the study
Sex hormone binding globulin (SHGB) (nmol/L)
Participants' serum SHGB was determined.
Time frame: change between the first day and the sixth month of the study
Free Androgen Index (FAI)
Free Androgen Index (FAI) was calculated according to the equation FAI = \[(Total testosterone/ SHBG) × 100\]
Time frame: change between the first day and the sixth month of the study
The Ferriman-Gallwey score (FGS)
The Ferriman-Gallwey score (FGS) was used to evaluate hirsutism.
Time frame: change between the first day and the sixth month of the study
fasting blood glucose (mg/dl)
Participants' fasting blood gucose was calculated.
Time frame: change between the first day and the sixth month of the study
fasting insulin (IU/ml)
Participants' fasting insulin was calculated.
Time frame: change between the first day and the sixth month of the study
HOMA-IR index
Participants' HOMA-IR index value was calculated using the "fasting blood glucose (mmol/L) x fasting insulin (μU/mL)/22.5" formula
Time frame: change between the first day and the sixth month of the study
QUICKI index
Participants' QUICKI index was calculated using the 1/\[log(fasting insulin in μU/ml)+log(fasting glucose in mg/dl)\].
Time frame: change between the first day and the sixth month of the study
Total cholesterol (mg/dl) composition
Participants' serum total cholesterol was determined.
Time frame: change between the first day and the sixth month of the study
high-density lipoprotein (HDL-C) (mg/dl)
Participants' serum HDL-C was determined.
Time frame: change between the first day and the sixth month of the study
low-density lipoprotein (LDL) (mg/dl)
Participants' serum LDL-C was determined.
Time frame: change between the first day and the sixth month of the study
triglyceride (mg/dl)
Participants' serum triglyceride was determined.
Time frame: change between the first day and the sixth month of the study
high-sensitivity CRP (HsCRP)(mg/l)
Participants' serum HsCRP was determined.
Time frame: change between the first day and the sixth month of the study
tumor necrosis factor-alpha (TNF-α) (pg/ml)
Participants' serum TNF-α determined.
Time frame: change between the first day and the sixth month of the study
interleukin-6 (IL-6) (pg/ml)
Participants' serum IL-6 determined.
Time frame: change between the first day and the sixth month of the study
Weight in kilograms
Body weight measurement was made.
Time frame: change between the first day and the sixth month of the study
Height in meters
Height was measured
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: change between the first day and the sixth month of the study
BMI = body mass index (kg/m2)
BMI = \[body weight (kg)/(height \[m\])2\]' was calculated
Time frame: change between the first day and the sixth month of the study
Neck circumference in cm
Neck circumference was measured
Time frame: change between the first day and the sixth month of the study
. Waist circumference in cm
waist circumference was measured
Time frame: change between the first day and the sixth month of the study
body composition analysis
body composition analysis (fat mass /kg), fat percentage (%), fat-free mass (kg)) were made by using the InBody 720 (1-1000 kHz; InBody Co., Ltd. Korea)
Time frame: change between the first day and the sixth month of the study